IBEX Technologies Overview

  • Status
  • Public
  • Employees
  • 9
Employees
  • Stock Symbol
  • IBT
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $0.20
  • (As of Wednesday Closing)

IBEX Technologies General Information

Description

Ibex Technologies Inc is a Canada based company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays which have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, the U.S, U.K, and other countries of which the majority of the revenue is generated from the U.S.

Contact Information

Website
Formerly Known As
Continental Pharma Cryosan
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Medical Supplies
Stock Exchange
TSX
Primary Office
  • 5485 Pare Street
  • Suite 100
  • Montreal, Quebec H4P 1P7
  • Canada
+1 (514) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IBEX Technologies Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.20 $0.21 $0.07 - $0.22 $4.91M 24.8M 25.3K

IBEX Technologies Financials Summary

In Thousands,
USD
TTM 30-Apr-2020 FY 2019 31-Jul-2019 FY 2018 31-Jul-2018 FY 2017 31-Jul-2017
EV 1,328 432 3,744 3,501
Revenue 3,692 3,254 3,713 4,022
EBITDA 325 (780) 223 638
Net Income 59 (957) (75) 2,251
Total Assets 6,812 6,378 7,250 7,650
Total Debt 1,136 755 795 836
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IBEX Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IBEX Technologies‘s full profile, request access.

Request a free trial

IBEX Technologies Executive Team (3)

Name Title Board Seat Contact Info
Paul Baehr Chief Executive Officer & Chairman
Mahendra Pallapothu Vice President
To view IBEX Technologies’s complete executive team members history, request access »

IBEX Technologies Board Members (4)

Name Representing Role Since
0000000 00000 IBEX Technologies Board Member 000 0000
0000 00000 IBEX Technologies Chief Executive Officer & Chairman 000 0000
To view IBEX Technologies’s complete board members history, request access »

IBEX Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IBEX Technologies Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000-00000000 00000 02-Jan-2013 000000000000000000 000 Other Pharmaceuticals and Biotechnology
00000000 28-Apr-2007 000000000000000000 00.000 Personal Products 0000 00000
OncoTherapeutics 08-May-2003 Merger/Acquisition 00000 Drug Discovery 0000 00000
To view IBEX Technologies’s complete acquisitions history, request access »

IBEX Technologies Subsidiaries (2)

Company Name Industry Location Founded
OncoTherapeutics Drug Discovery West Hollywood, CA 1992
000-00000000 00000 Other Pharmaceuticals and Biotechnology North Liberty, IA 0000
To view IBEX Technologies’s complete subsidiaries history, request access »